» Articles » PMID: 37040224

Delayed Adverse Reactions in Whole Blood Donors: Importance of Active Surveillance in Identifying the Missing Gaps in the Donor Safety

Overview
Specialty General Medicine
Date 2023 Apr 11
PMID 37040224
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Objectives: The information available regarding delayed adverse donor reactions (D-ADRs) is limited. Proactive follow up of donors for delayed reactions is not done routinely. This study was undertaken to analyze frequency and type of D-ADRs in whole blood donors as also the contributory factors.

Methods: In this prospective observational study, all eligible whole blood donors were contacted telephonically twice (24 h and 2 wks after donation) and asked about general health and ADR specific questions. The International Society of Blood Transfusion standard guidelines were used to categorize ADRs.

Results: The ADR data of 3514 donors were analyzed in the study. D-ADRs were more common as compared to immediate delayed adverse donor reactions (I-ADRs) (13.7 vs. 2.9%, P<0.001). The most common D-ADRs were bruises (4.98%), fatigue or generalized weakness (4.24%) and sore arms (2.25%). D-ADRs were more common in first time donors as compared to the repeat blood donors (16.1 vs. 12.5%, P=0.002). Females were more prone to D-ADRs (17 vs. 13.6%). Localized D-ADRs were more frequent as compared to systemic D-ADRs (P<0.001). Repeat donors had a lower incidence of systemic D-ADRs (4.11% vs. 7.37%, P<0.001).

Interpretation & Conclusions: D-ADRs were more common than I-ADRs with a different profile. First time, female and young donors were more prone to D-ADRs. These categories need special care at the time of blood donation. Active follow up of blood donors should be done from time to time to strengthen donor safety.

References
1.
Newman B, Pichette S, Pichette D, Dzaka E . Adverse effects in blood donors after whole-blood donation: a study of 1000 blood donors interviewed 3 weeks after whole-blood donation. Transfusion. 2003; 43(5):598-603. DOI: 10.1046/j.1537-2995.2003.00368.x. View

2.
Bajpai M, Gupta S, Chatterjee K . Are medicated adhesive bands at the phlebotomy site useful?. Indian J Hematol Blood Transfus. 2012; 25(2):86-7. PMC: 3452960. DOI: 10.1007/s12288-009-0021-7. View

3.
Custer B, Rios J, Schlumpf K, Kakaiya R, Gottschall J, Wright D . Adverse reactions and other factors that impact subsequent blood donation visits. Transfusion. 2011; 52(1):118-26. PMC: 3607355. DOI: 10.1111/j.1537-2995.2011.03216.x. View

4.
K Symvoulakis E, Lydaki E, Bolonaki I, Nikoloudi I, Kozyraki M, Fountouli P . Post donation adverse reactions among Greek blood donors: a preliminary report based on phone interviews. Transfus Apher Sci. 2009; 41(1):77-8. DOI: 10.1016/j.transci.2009.05.008. View

5.
Sojka P, Sojka B . Adverse effects in blood donors after whole-blood donation: you find what you look for!. Transfusion. 2003; 44(1):135-6. DOI: 10.1111/j.0041-1132.2004.00612.x. View